Skip to content

Pilot study for validation of range of motion(ROM) of shoulder joint in POM-Checker for healthy person

Pilot study for validation of range of motion(ROM) of shoulder joint in POM-Checker for healthy person

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0002851
Enrollment
6
Registered
2018-05-08
Start date
2018-03-15
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Wonkwang University, Gwangju Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) participants aged between 20 to 39 years 2) agreement on participation and providing written informed consent voluntarily after receiving a clear explanation of the clinical study purposes and characteristics. 3) participants without musculoskeletal disorders in the test joint area (shoulder joint)

Exclusion criteria

Exclusion criteria: 1) pregnant women and nursing mothers 2) history of liver, kidney, nervous system, immune system, respiratory, endocrine, cardiovascular, or circulatory disease, tumor, or mental illness 3) A person with a history of musculoskeletal disorders or mechanical abnormalities such as fractures, acute sprains, or tumors in the test site (shoulder joint) 4) Persons with severe disability in the shoulder movement due to severe pain at the joint site 5) Person who judged inappropriate for clinical examination by the examiner

Design outcomes

Primary

MeasureTime frame
Shoulder joint`s Range of Motion (Flexion, Extension, Abduction)

Secondary

MeasureTime frame
The agreement between the motion analyzer and the measured value of POM Cheker

Countries

Korea, Republic of

Contacts

Public ContactHongmin Chu

Wonkwang University

hongminchu2@gmail.com+82-62-670-6407

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026